Skip to main content

Life Sciences

iHelp Lifecycle and Version Control in Life sciences

Healthcare Data

Previously, I examined how to develop content and implement iHelp. In this final installment I discuss the iHelp lifecycle and control.

iHelp comes with a built-in version control system. When you create a new iHelp article, it starts at version 0, with a status of “In Progress.” You then enter and edit the content, testing as necessary while the status is still “In Progress.” By doing this, you can make the article visible for the Siebel Administrator (or other desired responsibility) but not change what end-users see.

Once satisfied, you “Activate” the article, which locks editing for that version and deactivates the old version (if there is one). After an article is active, you can either deactivate or revise it. If you deactivate it, iHelp removes it from visibility from all of its responsibilities, and the status changes to Inactive.

If you “Revise” it, a new version is generated with a status of “In Progress,” but this does not affect the current “Active” version. End users will continue to see the old version until you activate the new one. But, as mentioned earlier, you can still make “In Progress” articles visible to whatever responsibilities you like.

To learn more about iHelp and the assistance it can provide with Oracle’s Cloud Siebel CTMS, you can click here or fill out the form below.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Param Singh

Param Singh has been working in the life sciences industry his entire career. As the director of clinical trial management solutions at Perficient, he developed the clinical trial management team to become one of the best in the industry. Param leads a highly skilled team of implementation specialists and continues to build lasting relationships with clients. He has a knack for resource and project management, which allows clients to achieve success. Param has been with Perficient, via the acquisition of BioPharm Systems, since 2008. Prior to joining the company, he guided the clinical trial management group at Accenture.

More from this Author

Follow Us